LA HR289 | 2023 | Regular Session

Louisiana House Resolution 289 (Prior Session Legislation)

Status

Completed Legislative Action
Spectrum: Partisan Bill (Democrat 1-0)
Status: Passed on June 8 2023 - 100% progression
Action: 2023-06-09 - Taken by the Clerk of the House and presented to the Secretary of State in accordance with the Rules of the House.
Text: Latest bill text (Enrolled) [PDF]

Summary

Requests the Louisiana Department of Health to review Medicaid prior authorization criteria for L-glutamine which is used to treat acute complications caused by sickle cell disease

Title

Requests the Louisiana Department of Health to review Medicaid prior authorization criteria for L-glutamine which is used to treat acute complications caused by sickle cell disease

Roll Calls

2023-06-08 - House - House Vote on HR 289 FINAL CONSIDERATION (#1184) (Y: 96 N: 0 NV: 0 Abs: 9) [PASS]

History

Date	Chamber	Action
2023-06-09	House	Taken by the Clerk of the House and presented to the Secretary of State in accordance with the Rules of the House.
2023-06-08	House	Enrolled and signed by the Speaker of the House.
2023-06-08	House	Read by title, roll called, yeas 96, nays 0. The resolution was adopted.
2023-06-08	House	Called from the calendar.
2023-06-08	House	Read by title, returned to the calendar.
2023-06-07	House	Scheduled for floor debate on 06/08/2023.
2023-06-07	House	Read by title, rules suspended, passed to 3rd reading.

Subjects

MEDICAID

Louisiana State Sources

Type	Source
Summary	https://www.legis.la.gov/legis/BillInfo.aspx?s=23rs&b=HR289&sbi=y
Text	https://www.legis.la.gov/Legis/ViewDocument.aspx?d=1331329
Text	https://www.legis.la.gov/Legis/ViewDocument.aspx?d=1331744
Supplement	https://www.legis.la.gov/Legis/ViewDocument.aspx?d=1331330
Supplement	https://www.legis.la.gov/Legis/ViewDocument.aspx?d=1334817
Roll Call	https://www.legis.la.gov/Legis/ViewDocument.aspx?d=1331657